| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |